- Home
- GYRE vs WDH Comparison
GYRE vs WDH Comparison
Compare GYRE & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GYRE | WDH |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 679.4M | 596.7M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GYRE | WDH |
|---|---|---|
| Price | $7.88 | $1.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 45.4K | ★ 161.1K |
| Earning Date | 05-08-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 3.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $275,000.00 | N/A |
| Revenue This Year | $19.88 | N/A |
| Revenue Next Year | N/A | $8.71 |
| P/E Ratio | $388.50 | ★ $9.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.58 | $1.24 |
| 52 Week High | $11.77 | $2.18 |
Technical Indicators
Market Signals| Indicator | GYRE | WDH |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 30.48 |
| Support Level | $7.25 | $1.50 |
| Resistance Level | $7.91 | $1.74 |
| Average True Range (ATR) | 0.27 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 64.44 | 13.64 |
Price Performance
Historical ComparisonAbout GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.